Fig. 2: Cumulative incidence curves and log-log transformed cumulative incidence curves based on the days and the number of prescriptions for 12-month freedom outcomes. | npj Digital Medicine

Fig. 2: Cumulative incidence curves and log-log transformed cumulative incidence curves based on the days and the number of prescriptions for 12-month freedom outcomes.

From: Post-marketing surveillance of anticancer drugs using natural language processing of electronic medical records

Fig. 2

Left top: Cumulative incidence curve based on the days. a Comparison between oxaliplatin and cisplatin for peripheral neuropathy. b Comparison between docetaxel and paclitaxel for oral mucositis. Right top: Cumulative incidence curve based on the number of prescriptions. c Comparison between oxaliplatin and cisplatin for peripheral neuropathy. d Comparison between docetaxel and paclitaxel for oral mucositis. Left bottom: Log-log transformed cumulative incidence curve based on the days. e Comparison between oxaliplatin and cisplatin for peripheral neuropathy. f Comparison between docetaxel and paclitaxel for oral mucositis. Right bottom: g Comparison between oxaliplatin and cisplatin for peripheral neuropathy. h Comparison between docetaxel and paclitaxel for oral mucositis. In the log-log transformed cumulative incidence curve, the horizontal axis represents the natural logarithm of the days or the number of prescriptions, whereas the vertical axis denotes the natural logarithm of the cumulative incidence of the adverse event. For the horizontal axis, e1 approximately corresponds to 2.7 e2 to 7.4, and e3 to 20.1.

Back to article page